You may have noticed that Zantac is no longer on the shelf in many major pharmacies. If you’ve been taking Zantac to treat heartburn, you should know that the drug and all its generic versions have been recalled by their manufacturers. While this may not be cause for concern, Zantac’s active ingredient, ranitidine, has been linked to a probable carcinogen – or a substance that is likely to cause cancer.
If you have developed cancer after taking Zantac or another ranitidine heartburn medication, please contact Lauri J. Goldstein & Associates, PLLC today.
What Is Ranitidine and What Is It Contaminated With?
Ranitidine is an over the counter (OTC) H2 (histamine 2) blocker designed to decrease the amount of acid in the stomach and prevent heartburn. It is also prescribed in higher doses to patients who struggle with chronic heartburn. Most people know ranitidine by the brand-name Zantac, a version of the drug distributed by Sanofi. Sanofi was one of the last manufacturers to admit that its drugs were possibly contaminated by N-nitrosodimethylamine (NDMA). In testing, the U.S. Food and Drug Administration (FDA) has found all recalled samples to be contaminated with NDMA.
According to the Environmental Protection Agency (EPA), NDMA is classified as a probable human carcinogen and has been reasonably anticipated to cause cancer in humans when administered in large doses. Nevertheless, NDMA is an environmental contaminant that appears in small doses in our food and water, especially dairy products, vegetables, and grilled meats. Consuming small amounts of NDMA is unlikely to give you cancer, but some ranitidine medications contained more than the daily limit of 96 nanograms of NDMA.
As such, taking ranitidine medications could have put consumers at an increased risk for cancer.
What We Recommend
The FDA has encouraged all companies to recall their ranitidine drugs if testing shows NDMA levels that exceed 96 nanograms or 0.32 parts per million of NDMA. You will not be able to purchase these recalled drugs and should always dispose of recalled products you have at home.
Health care providers have also been alerted of NDMA impurities in prescription ranitidine medications. If you are currently taking prescription ranitidine, you may want to discuss alternative treatment options with your doctor.
Most importantly, you need to get in touch with our experienced dangerous drug attorneys if you have been diagnosed with cancer after taking Zantac or ranitidine.
Many lawsuits are expected to emerge in the coming months. You should not have to face the consequences of NDMA exposure alone.
Even if you are concerned about your health and risk-factors after taking ranitidine medications, you should discuss your case with our firm at (866) 675-4427 or request a free consultation online.